Sunday, August 14, 2016

BRIEF-Basilea Pharmaceutica H1 net loss narrows to CHF 27.9 million

* Contract revenue in first half-year of 2016 amounted to

27.8 million Swiss francs ($28.50 million) (H1 2015: 24.4

million francs)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)